A phase 2/3, multicenter trial of lenzilumab and azacitidine in chronic myelomonocytic leukemia: The PREACH-M trial

Hiwase, D; Ross, D; Lane, S; Yong, A; Sharplin, K; Yeung, D; Butler, L; Chappell, D; Durrant, C; Hughes, T; Thomas, D

CANCER RESEARCH, 2023; 83 (8):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索